DNB-001
DNB-001 Uses, Dosage, Side Effects, Food Interaction and all others data.
DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed for the treatment of glaucoma. In preclinical animal models, DNB-001 has demonstrated potent IOP- lowering effects as well as neuroprotective effects on the optic nerve.
Trade Name | DNB-001 |
Generic | DNB-001 |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in ocular hypertension.
Innovators Monograph
You find simplified version here DNB-001